Vendor Qualification Checklists for AI and ML Quality Platforms Vendor Qualification Checklists for AI and ML Quality Platforms In the rapidly evolving pharmaceutical and biotechnology industries, the integration of Artificial Intelligence (AI) and Machine Learning (ML) into quality systems is becoming increasingly prevalent. Regulatory Affairs (RA) professionals are tasked with ensuring that all vendors providing such AI and ML platforms meet stringent compliance standards. This article serves as a comprehensive regulatory manual on vendor qualification audits for AI and ML quality platforms, particularly focusing on Good Practice (GxP) suppliers, data integrity, cloud AI, algorithm transparency, and vendor oversight. Regulatory Context…

Auditing AI software suppliers for GxP compliance and data integrity Auditing AI Software Suppliers for GxP Compliance and Data Integrity In the ever-evolving pharmaceutical and biotechnology landscape, ensuring compliance with Good Practices (GxP) in Artificial Intelligence (AI) software is critical. As organizations integrate AI/ML technologies into their systems, competent regulatory affairs practitioners must execute thorough AI vendor qualification audits to ensure data integrity, quality, and regulatory compliance. This manual explores the relevant regulations, essential guidelines, and best practices for auditing AI software suppliers in the context of GxP compliance. Regulatory Context Regulatory Affairs (RA) professionals operate in a complex environment…

Contract Terms to Address AI Model Risk and Lifecycle Responsibilities Contract Terms to Address AI Model Risk and Lifecycle Responsibilities The integration of Artificial Intelligence (AI) and Machine Learning (ML) into the pharmaceutical and biotechnology landscape is transforming traditional practices, particularly in Quality Assurance (QA) and Quality Control (QC). As companies increasingly rely on cloud-based AI platforms and third-party vendors, regulatory affairs professionals must ensure compliance with global regulations and guidelines. This article provides a comprehensive overview of vendor qualification audits focused on AI systems within Good Practice (GxP) frameworks, emphasizing the necessary contract terms to manage risk and lifecycle…

Assessing algorithm transparency and explainability during vendor selection Assessing Algorithm Transparency and Explainability During Vendor Selection In the evolving landscape of pharmaceuticals and biotechnology, the adoption of Artificial Intelligence (AI) and Machine Learning (ML) is increasingly shaping Quality Management Systems (QMS). These advancements introduce complex considerations for Regulatory Affairs (RA) professionals, particularly regarding vendor qualification and audits for AI/ML quality platforms. This article serves as a comprehensive guide for assessing algorithm transparency and explainability during the vendor selection process, aligning with the expectations of regulatory agencies such as the FDA, EMA, and MHRA. Regulatory Affairs Context As the pharmaceutical industry…

Case Studies of AI Vendor Issues Uncovered During Quality Audits Case Studies of AI Vendor Issues Uncovered During Quality Audits Introduction to Regulatory Affairs in AI Vendor Qualification The integration of Artificial Intelligence (AI) technologies into pharmaceutical and biotechnology operations brings both opportunities and challenges, particularly concerning regulatory compliance. As organizations increasingly rely on AI-driven solutions, the necessity for robust vendor qualification processes becomes paramount. Regulatory Affairs (RA) professionals play a critical role in ensuring that AI vendors meet the necessary Good Practice (GxP) requirements, ultimately safeguarding data integrity and patient safety. Legal and Regulatory Basis In the context of…

Building a Risk Based Vendor Oversight Program for AI Tools Building a Risk Based Vendor Oversight Program for AI Tools As the adoption of Artificial Intelligence (AI) and Machine Learning (ML) in pharmaceutical and biotechnology sectors continues to accelerate, regulatory professionals must navigate the complexities of vendor qualification and oversight. This article provides a structured exploration of how to establish a risk-based vendor oversight program, focusing on AI vendor qualification audits, and addressing compliance with regulations and guidelines established by authorities including the FDA, EMA, and MHRA. Regulatory Affairs Context Vendor oversight in the context of AI tools involves ensuring…

Due diligence questions for cloud based AI quality platforms Due diligence questions for cloud based AI quality platforms Context The adoption of Artificial Intelligence (AI) and Machine Learning (ML) technologies in the pharmaceutical and biotech sectors has revolutionized various processes, from drug discovery to quality control (QC) systems. However, leveraging cloud-based AI quality platforms necessitates thorough vendor qualification audits to ensure compliance with regulatory standards. Vendors must be adequately vetted to ensure they meet Good Practice (GxP) requirements for quality systems, data integrity, and algorithm transparency. Regulatory Affairs (RA) professionals play a crucial role in this process, providing guidance on…

How to document vendor assessments for AI enabled systems in QMS How to document vendor assessments for AI enabled systems in QMS Regulatory Affairs Context The advent of Artificial Intelligence (AI) and Machine Learning (ML) technologies in Quality Management Systems (QMS) has revolutionized the pharmaceutical and biotechnology industries. With increasing reliance on AI for processes such as data integrity, decision-making, and predictions, it is imperative that Regulatory Affairs (RA) professionals understand the necessary framework for vendor qualification and audits specifically tailored for AI-enabled systems. This article aims to provide a comprehensive guide on how to effectively conduct and document vendor…

Regulatory expectations when using third party AI products in GMP Regulatory Expectations When Using Third Party AI Products in GMP The increasing integration of Artificial Intelligence (AI) into Good Manufacturing Practice (GMP) environments presents both opportunities and challenges for regulatory professionals. As organizations begin to implement AI and machine learning (ML) platforms from external vendors, understanding the regulatory landscape is essential. This comprehensive manual offers a structured overview of relevant regulations, guidelines, and agency expectations concerning vendor qualification audits for AI/ML products in GMP settings. Context Regulatory Affairs (RA) serves as a vital bridge between companies and regulatory authorities. In…

Ongoing Monitoring KPIs for AI Vendor Performance and Compliance Ongoing Monitoring KPIs for AI Vendor Performance and Compliance In the context of pharmaceutical and biotechnology development, the integration of Artificial Intelligence (AI) and Machine Learning (ML) into Quality Systems presents unique regulatory challenges and opportunities. As life sciences organizations increasingly utilize AI/ML technology to streamline operations, enhance decision-making, and ensure compliance, robust frameworks for vendor qualification audits are imperative. This article serves as a comprehensive guide for regulatory professionals in the US, UK, and EU to navigate the ongoing monitoring of Key Performance Indicators (KPIs) for AI vendor performance and…